IRCT20200623047902N10已完成未知
Bioequivalence study of Tacrolimus 1mg ( Taclirus) manufactured by Alborz Zagros company versus originator brand in healthy volunteers in fasting condition
Alborz Zagros company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Tacrolimus
研究者
相似试验
已完成
4 期
A comparative study of the efficacy of tacrolimus with infliximab in intractable ulcerative colitislcerative colitisJPRN-UMIN000010612Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine130
招募中
3 期
Effect of Tacrolimus in treatment of Recurrent Implantation FailureIRCT20240429061583N1Iranian academic center for education culture and research162
已完成
1 期
Bioequivalence Study of Tacrolimus in Healthy VolunteersHealthy VolunteersNCT04725682Food and Drug Administration (FDA)67
招募中
不适用
Examination of efficacy and safety of tacrolimus, immunomodulator for an outpatient with moderate to severe ulcerative colitisulcerative colitisJPRN-UMIN000005824Juntendo University20
已完成
4 期
A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver TransplantationLiver TransplantationNCT01339468Astellas Pharma Inc100